Health tech start-up snap40 has a clear mission to change healthcare globally by enabling hospitals to catch deteriorating health earlier using its own medical-grade vital signs monitoring wearable arm-band and accompanying analysis software platform. The Scottish start-up, led by CEO and co-founder, Christopher McCann – a former medical student at the University of Dundee who left in his third year to found the company – has secured £2M in funding in what is thought to be the largest ever seed round by a Scotland-based start-up.
The first tranche of the investment – led by Edinburgh-based investment firm Par Equity – closed at the end of September and will allow the company to grow its already highly skilled engineeringand data science team, complete clinical trials and gain regulatory clearance, opening up the entire EU market. The company also plans to move quickly into the US market, opening a US office in 2017.
